Research ExplorerJournalsJ NEURAL TRANSM Publications

J NEURAL TRANSM

1 - 32 out of 32Page size: 50

Publications

  1. 2024

  2. Correction to: Role of dopamine agonists in Parkinson's disease therapy

    Woitalla, D., Buhmann, C., Hilker-Roggendorf, R., Höglinger, G., Koschel, J., Müller, T. & Weise, D., 09.2024, In: J NEURAL TRANSM. 131, 9, p. 1145

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  3. Therapeutic use of medical Cannabis in neurological diseases: a clinical update

    Hidding, U., Mainka, T. & Buhmann, C., 02.2024, In: J NEURAL TRANSM. 131, 2, p. 117-126 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  4. 2023

  5. Blood neurofilament light chain in Parkinson's disease

    Buhmann, C., Magnus, T. & Choe, C-U., 06.2023, In: J NEURAL TRANSM. 130, 6, p. 755-762 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  6. Role of dopamine agonists in Parkinson's disease therapy

    Woitalla, D., Buhmann, C., Hilker-Roggendorf, R., Höglinger, G., Koschel, J., Müller, T. & Weise, D., 06.2023, In: J NEURAL TRANSM. 130, 6, p. 863-873 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  7. Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

    Huber, F., Schulz, J., Schlack, R., Hölling, H., Ravens-Sieberer, U., Meyer, T., Rothenberger, A., Wang, B. & Becker, A., 04.2023, In: J NEURAL TRANSM. 130, 4, p. 597-609 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study

    Leplow, B., Renftle, D., Thomas, M., Michaelis, K., Solbrig, S., Maetzler, W., Berg, D. & Liepelt-Scarfone, I., 02.2023, In: J NEURAL TRANSM. 130, 2, p. 125-133 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2022

  10. Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice

    Tönges, L., Buhmann, C., Klebe, S., Klucken, J., Kwon, E. H., Müller, T., Pedrosa, D. J., Schröter, N., Riederer, P. & Lingor, P., 09.2022, In: J NEURAL TRANSM. 129, 9, p. 1201-1217 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  11. More focal, less heterogeneous? Multi-level meta-analysis of cathodal high-definition transcranial direct current stimulation effects on language and cognition

    Ostrowski, J., Svaldi, J. & Schröder, P. A., 07.2022, In: J NEURAL TRANSM. 129, 7, p. 861-878 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  12. Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network

    Benson, G. S., Bauer, C., Hausner, L., Couturier, S., Lewczuk, P., Peters, O., Hüll, M., Jahn, H., Jessen, F., Pantel, J., Teipel, S. J., Wagner, M., Schuchhardt, J., Wiltfang, J., Kornhuber, J. & Frölich, L., 06.2022, In: J NEURAL TRANSM. 129, 5-6, p. 477-486 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson's disease in the MARK-PD study

    Pötter-Nerger, M., Dutke, J., Lezius, S., Buhmann, C., Schulz, R., Gerloff, C., Kuhle, J. & Choe, C-U., 03.2022, In: J NEURAL TRANSM. 129, 3, p. 295-300 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2021

  15. Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry

    Hansen, N., Luedecke, D., Malchow, B., Lipp, M., Vogelgsang, J., Timäus, C., Zindler, T., Gingele, S., Kühn, S., Gallinat, J., Wiedemann, K., Denk, J., Moschny, N., Fiehler, J., Skripuletz, T., Riedel, C., Wattjes, M. P., Zerr, I., Esselmann, H., Poustka, L., Karow, A., Hartmann, H., Frieling, H., Bleich, S., Wiltfang, J., Neyazi, A. & CAP (Cerebrospinal Fluid Analysis in Psychiatry) Consortium, 06.2021, In: J NEURAL TRANSM. 128, 6, p. 735-747 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  16. 2019

  17. Discussing sexuality with Parkinson's disease patients: a multinational survey among neurologists

    de Rooy, F. B. B., Buhmann, C., Schönwald, B., Martinez-Martin, P., Rodriguez-Blazquez, C., Putter, H., Elzevier, H. W. & van der Plas, A. A., 10.2019, In: J NEURAL TRANSM. 126, 10, p. 1273-1280 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Stressful life events are associated with striatal dopamine receptor availability in alcohol dependence

    Sebold, M., Spitta, G., Gleich, T., Dembler-Stamm, T., Butler, O., Zacharias, K., Aydin, S., Garbusow, M., Rapp, M., Schubert, F., Buchert, R., Gallinat, J. & Heinz, A., 09.2019, In: J NEURAL TRANSM. 126, 9, p. 1127-1134 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Dyskinesia in multiple system atrophy and progressive supranuclear palsy

    Jost, W. H., Lingor, P., Tönges, L., Schwarz, J., Buhmann, C., Kassubek, J. & Schrag, A., 07.2019, In: J NEURAL TRANSM. 126, 7, p. 925-932 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  20. Evidence for the use of cannabinoids in Parkinson's disease

    Buhmann, C., Mainka, T., Ebersbach, G. & Gandor, F., 07.2019, In: J NEURAL TRANSM. 126, 7, p. 913-924 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Deep brain stimulation via segmented leads in the subthalamic nucleus in Parkinson's disease-impact on axial symptoms

    Kirsten, M., Junak, C., Gulberti, A., Gerloff, C., Hamel, W., Moll, C. & Pötter-Nerger, M., 01.05.2019, In: J NEURAL TRANSM. 2019, Vol. 126. No. 5, p. 690 1 p., Vol. 126. No. 5.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  22. 2018

  23. The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care

    Fründt, O., Mainka, T., Schönwald, B., Müller, B., Dicusar, P., Gerloff, C. & Buhmann, C., 10.2018, In: J NEURAL TRANSM. 125, 10, p. 1461-1472 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2017

  25. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients

    Kübler, D., Schroll, H., Buchert, R. & Kühn, A., 09.2017, In: J NEURAL TRANSM. 124, 9, p. 1073-1081

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy

    Buhmann, C., Hilker, R., Lingor, P., Schrader, C., Schwarz, J., Wolz, M. & Reichmann, H., 08.2017, In: J NEURAL TRANSM. 124, 8, p. 1005-1013

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 2016

  28. The impact of Parkinson disease on patients´ sexuality and relationship

    Buhmann, C., Dogac, S., Vettorazzi, E., Hidding, U., Gerloff, C. & Jürgens, T. P., 19.11.2016, In: J NEURAL TRANSM. 124, 8, p. 983-996

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD

    Feneberg, E., Steinacker, P., Volk, A. E., Weishaupt, J. H., Wollmer, M. A., Boxer, A., Tumani, H., Ludolph, A. C. & Otto, M., 01.03.2016, In: J NEURAL TRANSM. 123, 3, p. 289-96

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Wearable sensor-based objective assessment of motor symptoms in Parkinson's disease

    Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J. & Storch, A., 01.2016, In: J NEURAL TRANSM. 123, 1, p. 57-64 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2009

  32. Estrus cyclicity of spinogenesis: underlying mechanisms.

    Prange-Kiel, J., Fester, L., Zhou, L., Jarry, H. & Rune, G. M., 2009, In: J NEURAL TRANSM. 116, 11, p. 1417-1425 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly.

    Kölsch, H., Wagner, M., Bilkei-Gorzó, A., Toliat, M. R., Pentzek, M., Fuchs, A., Kaduszkiewicz, H., Bussche van den, H., Riedel-Heller, S. G., Angermeyer, M. C., Weyerer, S., Werle, J., Bickel, H., Mösch, E., Wiese, B., Daerr, M., Jessen, F., Maier, W. & Dichgans, M., 2009, In: J NEURAL TRANSM. 116, 7, p. 897-903 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Role of Reelin in the development and maintenance of cortical lamination.

    Frotscher, M., Chai, X., Bock, H., Haas, C., Förster, E. & Zhao, S., 2009, In: J NEURAL TRANSM.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2007

  36. Chronic dose effects of reboxetine on motor skill acquisition and cortical excitability.

    Lange, R., Weiller, C. & Liepert, J., 2007, In: J NEURAL TRANSM. 114, 8, p. 1085-1089 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.

    Sabunciyan, S., Kirches, E., Krause, G., Bogerts, B., Mawrin, C., Llenos, I. C. & Weis, S., 2007, In: J NEURAL TRANSM. 114, 5, p. 665-674 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. 2004

  39. Modulation of motor cortex excitability induced by pinch grip repetition.

    Gorsler, A., Zittel, S., Weiller, C., Münchau, A. & Liepert, J., 2004, In: J NEURAL TRANSM. 111, 8, p. 1005-1016 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2003

  41. CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

    Ganzer, S., Arlt, S., Schoder, V., Buhmann, C., Mandelkow, E-M., Finckh, U., Beisiegel, U., Naber, D. & Müller-Thomsen, T., 2003, In: J NEURAL TRANSM. 110, 10, p. 1149-1160 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2002

  43. COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease.

    Oechsner, M., Buhmann, C., Strauss, J. & Stuerenburg, H. J., 2002, In: J NEURAL TRANSM. 109, 1, p. 69-75 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2001

  45. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies

    Ferrer, I., Blanco, R., Carmona, M., Puig, B., Barrachina, M., Gómez, C., Ambrosio, S. & Puig Martorell, B., 01.01.2001, In: J NEURAL TRANSM. 108, 12, p. 1383-96 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies

    Ferrer, I., Blanco, R., Carmona, M., Puig, B. & Puig Martorell, B., 01.01.2001, In: J NEURAL TRANSM. 108, 12, p. 1397-415 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review